158 related articles for article (PubMed ID: 38024961)
1. Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an
Haq KU; Sa'adah NL; Siswanto I; Suwito H
RSC Adv; 2023 Nov; 13(49):34348-34357. PubMed ID: 38024961
[TBL] [Abstract][Full Text] [Related]
2. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
Taidi L; Maurady A; Britel MR
J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
[TBL] [Abstract][Full Text] [Related]
4. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation.
Ayman R; Radwan AM; Elmetwally AM; Ammar YA; Ragab A
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200395. PubMed ID: 36336646
[TBL] [Abstract][Full Text] [Related]
6. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-
Peregrym K; Szczukowski Ł; Wiatrak B; Potyrak K; Czyżnikowska Ż; Świątek P
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502040
[TBL] [Abstract][Full Text] [Related]
8. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
10. Bioactivity-Guided Synthesis: In Silico and In Vitro Studies of
Khushal A; Farooq U; Khan S; Rasul A; Wani TA; Zargar S; Shahzad SA; Bukhari SM; Khan NA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764324
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided approach on the role of substitution on amide-linked bipyrazoles and its effect on their anti-inflammatory activity.
Domiati SA; Abd El Galil KH; Abourehab MAS; Ibrahim TM; Ragab HM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2179-2190. PubMed ID: 35950562
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors.
Grover J; Kumar V; Singh V; Bairwa K; Sobhia ME; Jachak SM
Eur J Med Chem; 2014 Jun; 80():47-56. PubMed ID: 24763362
[TBL] [Abstract][Full Text] [Related]
13. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
14. The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation.
Antonopoulou I; Sapountzaki E; Rova U; Christakopoulos P
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892687
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions.
Gundogdu-Hizliates C; Alyuruk H; Gocmenturk M; Ergun Y; Cavas L
Bioorg Chem; 2014 Feb; 52():8-15. PubMed ID: 24270352
[TBL] [Abstract][Full Text] [Related]
16. Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies.
Rashad AY; Kassab SE; Daabees HG; Abdel Moneim AE; Rostom SAF
Bioorg Chem; 2021 Aug; 113():104948. PubMed ID: 34052736
[TBL] [Abstract][Full Text] [Related]
17. Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints.
Rudrapal M; Kirboga KK; Abdalla M; Maji S
Mol Divers; 2024 Jan; ():. PubMed ID: 38200203
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
Rezvani S; Ebadi A; Razzaghi-Asl N
J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
[TBL] [Abstract][Full Text] [Related]
19. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies.
Darwish SA; El-Kerdawy MM; Elsheakh AR; Abdelrahman RS; Shaldam MA; Abdel-Aziz HA; Hassan GS; Ghaly MA
Bioorg Chem; 2022 Mar; 120():105644. PubMed ID: 35121552
[TBL] [Abstract][Full Text] [Related]
20. Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach.
Sadeghi M; Miroliaei M; Fateminasab F; Moradi M
J Mol Model; 2021 Dec; 28(1):24. PubMed ID: 34970708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
